GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Minority Interest

Femtobiomed (XKRX:327610) Minority Interest : ₩0.00 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Femtobiomed's minority interest for the quarter that ended in Dec. 2024 was ₩0.00 Mil.


Femtobiomed Minority Interest Historical Data

The historical data trend for Femtobiomed's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed Minority Interest Chart

Femtobiomed Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Minority Interest
Get a 7-Day Free Trial - - - - -

Femtobiomed Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Minority Interest Get a 7-Day Free Trial - - - - -

Femtobiomed Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.


Femtobiomed Business Description

Traded in Other Exchanges
N/A
Address
17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487
Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed Headlines

No Headlines